1. Home
  2. AIR vs RCUS Comparison

AIR vs RCUS Comparison

Compare AIR & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AAR Corp.

AIR

AAR Corp.

HOLD

Current Price

$82.42

Market Cap

3.3B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.47

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIR
RCUS
Founded
1951
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
1988
2018

Fundamental Metrics

Financial Performance
Metric
AIR
RCUS
Price
$82.42
$21.47
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$89.00
$29.38
AVG Volume (30 Days)
339.5K
2.1M
Earning Date
01-06-2026
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.81
N/A
Revenue
$2,858,400,000.00
$240,000,000.00
Revenue This Year
$12.82
N/A
Revenue Next Year
$9.18
N/A
P/E Ratio
$103.44
N/A
Revenue Growth
17.59
N/A
52 Week Low
$46.51
$6.50
52 Week High
$89.69
$26.40

Technical Indicators

Market Signals
Indicator
AIR
RCUS
Relative Strength Index (RSI) 51.04 42.60
Support Level $78.62 $20.35
Resistance Level $85.35 $26.10
Average True Range (ATR) 2.61 1.48
MACD 0.20 -0.59
Stochastic Oscillator 56.46 18.43

Price Performance

Historical Comparison
AIR
RCUS

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: